The purpose of Amendment 2 is to extend the proposal due date to 9/11/2020 at 5:00pm EST. Due to additional inquiries from potential offerors, the FDA has determined a need to issue an updated solicitation with additional clarifying information. The revised solicitation documentation will be issued as soon as possible under Amendment 3 to this solicitation notice
Extending the due date to 09/16/2020 at 5pm est., Questions due 09/14/2020 at 2pm est. Amendment 3 will be posted on 09/11/2020.
Amendment 3 RFQ-20-RFQ-1224178B
QUESTIONS AND ANSWERS RFQ-20-RFQ-1224178B AMENDMENT 3